Hong Liag Wu

Director Financiero/CFO en Jumpcan Pharmaceutical Co. Ltd. .

46 años

Health Technology

Perfil

Hong Liag Wu is currently working as the Chief Financial Officer & Secretary at Jumpcan Pharmaceutical Co. Ltd.
Previously, Wu worked as the Chief Financial Officer & Board Secretary at Hubei Jumpcan Pharmaceutical Co., Ltd.

Cargos activos de Hong Liag Wu

Empresas	Cargo	Inicio
Jumpcan Pharmaceutical Co. Ltd. Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million.	Director Financiero/CFO	-

Todos los cargos activos de Hong Liag Wu

Antiguos cargos conocidos de Hong Liag Wu.

Empresas	Cargo	Fin
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	Director Financiero/CFO	-

Ver el detalle de la experiencia de Hong Liag Wu.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Hong Liag Wu.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	Health Technology

Empresas privadas	1
Jumpcan Pharmaceutical Co. Ltd. Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million.	Health Technology